ustransplant.org

Transplant Statistics: Annual Report : Reference Tables

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Table 8.6a
Immunosuppression Use for Induction, 1992 to 2001
Recipients with Kidney-Pancreas Transplants

  Year of Transplant
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
Transplants 493 661 748 919 860 853 972 938 913 886
Tx With Immunosuppression Info 493 659 747 918 859 851 965 920 893 845
No Induction Drugs Recorded 80.7% 70.7% 51.5% 34.4% 18.5% 25.7% 40.6% 35.1% 26.7% 23.3%
Drugs 0.0% 0.0% 0.0% 0.0% 0.0% - - - - -
ALG
ATG 1.2% 2.4% 1.3% 6.6% 30.6% 32.8% 12.4% 5.9% 2.9% 2.6%
NRATG/NRATS - - 0.1% 0.4% 1.6% 4.0% 1.0% 0.4% 0.1% -
OKT3 18.1% 27.3% 47.5% 60.5% 52.4% 42.8% 27.9% 15.8% 8.3% 3.6%
Thymoglobulin - - - - 0.2% 0.1% 0.4% 8.7% 23.2% 28.6%
Zenapax - - 0.1% 0.3% 0.1% 0.2% 15.3% 25.7% 22.1% 20.6%
Simulect 0.0% 0.0% 0.1% 0.3% 0.1% 0.4% 6.7% 16.7% 26.8% 31.8%

Source: OPTN/SRTR Data as of August 1, 2002.
(-) = Drug not used anytime during the year.
Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte
receptors.

Annual Report | Chapters | Data By Category | Data By Organ | Technical Notes | Glossary | Appendices

Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline

Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map

SRTR Site designed and maintained by Diamond Bullet Design & URREA.